Off-label use of paclitaxel and pembrolizumab in a case of platinum refractory epithelial ovarian cancer and extensive thromboembolism

• Clarissa Lam,
• Kristal Ha,
• Ardeshir Hakam,
• Mian M.K. Shahzad

Affiliations

Clarissa Lam

Department of Gynecologic Oncology, H. Lee Moffitt Cancer Center and Department of Obstetrics and Gynecology, University of South Florida, Tampa, FL, USA

Kristal Ha

Department of Gynecologic Oncology, H. Lee Moffitt Cancer Center and Department of Obstetrics and Gynecology, University of South Florida, Tampa, FL, USA

Ardeshir Hakam

Department of Anatomic Pathology, H. Lee Moffitt Cancer Center, Tampa, FL, USA

Mian M.K. Shahzad

Department of Gynecologic Oncology, H. Lee Moffitt Cancer Center and Department of Oncologic Sciences, University of South Florida, Morsani School of Medicine, Tampa, FL, USA; Corresponding author at: H. Lee Moffitt Cancer Center and University of South Florida, 12902 Magnolia Drive, CSB GYN 1, Tampa, FL 33612, USA.